Cytokinetics Inc (CYTK) Stock Price, Quote, News & History

CYTKNASDAQ
$80.75
-1.87-2.26%
Last update: Jul 16, 1:02 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-523.85M
Investing Cash Flow (TTM)
56.20M
Financing Cash Flow (TTM)
527.47M
Free Cash Flow (TTM)
-548.92M
Capital Expenditure (TTM)
-25.07M
Net Change in Cash (TTM)
59.83M

Analyst Trends and Forecast

2
1
Mar
2
Apr
8
May
3
Jun
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$11.69B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
94.71
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-8.29%
Earnings Yield % (FWD)
-7.52%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$6.09

Company Debt

Total Debt
$1.16B
LT Debt
$1.12B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$413.36M
Total Cash
$129.84M
Debt to Equity
-
Issuance of Debt (TTM)
$316.10M
Repayment of Debt (TTM)
-$413.36M

Key Statistics

Open
$82.73
Close
-
Volume / Avg.
490.38K / 2.58M
Day Range
$80.09 - $83.71
52 Wk Range
32.89 - 88.31
Market Cap
$10.96B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
20.01%
Days to Cover
5.27

About

Sector
Health Care
Industry
Biotechnology
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cytokinetics (CYTK) stock?

A

You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cytokinetics (CYTK) competitors?

A

There are no as such competitors for Cytokinetics.

Q

What is the forecast, or price target, for Cytokinetics (CYTK) stock?

A

Cytokinetics has a consensus price target of $96.73.

Q

What is the current price for Cytokinetics (CYTK)?

A

The stock price for Cytokinetics (NASDAQ: CYTK) is $80.75 last updated July 16, 2026 at 1:02 PM EDT.

Q

Does Cytokinetics (CYTK) pay a dividend?

A

There are no upcoming dividends for Cytokinetics.

Q

When is Cytokinetics (NASDAQ:CYTK) reporting earnings?

A

Cytokinetics does not have any upcoming earnings scheduled.

Q

Is Cytokinetics (CYTK) going to split?

A

There is no upcoming split for Cytokinetics.

Q

What sector and industry does Cytokinetics (CYTK) operate in?

A

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.